Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCARDIOVASCULAR

Cardioprotection of Interleukin-2 Is Mediated via κ-Opioid Receptors

Chun-Mei Cao, Qiang Xia, Jie Tu, Mai Chen, Song Wu and Tak-Ming Wong
Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 560-567; DOI: https://doi.org/10.1124/jpet.103.061135
Chun-Mei Cao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qiang Xia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jie Tu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mai Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Song Wu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tak-Ming Wong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

We examined whether interleukin-2 (IL-2) protects the myocardium against injury induced by ischemia and reperfusion via the κ-opioid receptor (OR). The cardioprotective effect of IL-2 was evaluated by measuring infarct size and lactate dehydrogenase (LDH) release in response to ischemia and reperfusion in the isolated rat heart. IL-2 at an optimal dose of 50 U/ml mimicked the effect of ischemic preconditioning by reducing infarct size and LDH release. The infarct and LDH-reducing effects of IL-2 were blocked by nor-binaltorphimine (5 μM), a κ-OR antagonist, but not naltrindole (5 μM), a δ-OR antagonist known to block the action of its stimulation. Moreover, blockade of the mitochondrial ATP-sensitive potassium (mito-KATP) channel with a selective antagonist, 5-hydroxydecanoate (100 μM), or a nonselective antagonist of KATP channels, glybenclamide (100 μM), or blockade of protein kinase C (PKC) with its inhibitors chelerythrine (5 μM) or GF 109203X (10 μM) [3-[1-[3-(dimethylaminopropyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione monohydrochloride] abolished the protective effect of IL-2. Administration of free radical scavengers N-acetylcysteine (4 mM) or N-(2-mercaptopropionyl)-glycine (1 mM) also abolished the protective effects of IL-2 and U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide], a selective κ-OR agonist. This study provides the first evidence that IL-2 confers cardioprotection against injury induced by ischemia/reperfusion. The effect of IL-2 is mediated via κ-OR as evidenced by κ-OR antagonism and similar signaling mechanisms, mito-KATP, PKC, and reactive oxygen species involved in the cardioprotective effects of both IL-2 and κ-OR stimulation.

Footnotes

  • The study was supported by a Cardiovascular Physiology Research Fund donated by L.C.S.T. (Holdings), Ltd.

  • Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.

  • DOI: 10.1124/jpet.103.061135.

  • ABBREVIATIONS: IPC, ischemia preconditioning; OR, opioid receptor; mito-KATP, mitochondrial ATP-sensitive potassium; PKC, protein kinase C; IL-2, interleukin-2; ROS, reactive oxygen species; LVEDP, left ventricular end diastolic pressure; HR, heart rate; LVDP, left ventricular developed pressure; CF, coronary flow; NTD, naltrindole; nor-BNI, nor-binaltorphimine; 5-HD, 5-hydroxydecanoate; Gly, glybenclamide; Che, chelerythrine; NAC, N-acetylcysteine; 2-MPG, N-(2-mercaptopropionyl)-glycine; U50,488H, (trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide; GF 109203X, 3-[1-[3-(dimethylaminopropyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione monohydrochloride.

    • Received October 6, 2003.
    • Accepted January 26, 2004.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 309 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 309, Issue 2
1 May 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cardioprotection of Interleukin-2 Is Mediated via κ-Opioid Receptors
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCARDIOVASCULAR

Cardioprotection of Interleukin-2 Is Mediated via κ-Opioid Receptors

Chun-Mei Cao, Qiang Xia, Jie Tu, Mai Chen, Song Wu and Tak-Ming Wong
Journal of Pharmacology and Experimental Therapeutics May 1, 2004, 309 (2) 560-567; DOI: https://doi.org/10.1124/jpet.103.061135

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCARDIOVASCULAR

Cardioprotection of Interleukin-2 Is Mediated via κ-Opioid Receptors

Chun-Mei Cao, Qiang Xia, Jie Tu, Mai Chen, Song Wu and Tak-Ming Wong
Journal of Pharmacology and Experimental Therapeutics May 1, 2004, 309 (2) 560-567; DOI: https://doi.org/10.1124/jpet.103.061135
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Optimized S-nitrosohemoglobin synthesis in red blood cells
  • High-Salt Diet Upregulates CaSR Expression and Signaling
  • L-Arginine improves post-infarction physical function
Show more Cardiovascular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics